Table 6. Comparison of pharmacokinetics between male and female patients administered pegylated liposomal doxorubicin.
Parameters | Male (n=6) | Female (n=3) | P Valuea |
---|---|---|---|
AUC(0–∞) (g/L·h) | 0.8±0.5 | 1.1±0.3 | 0.316 |
AUC(0–t) (g/L·h) | 0.6±0.3 | 0.9±0.2 | 0.234 |
CL (L·h−1·m−2) | 0.051±0.027 | 0.027±0.008 | 0.199 |
Cmax (mg/L) | 9.5±2.9 | 10.8±3.6 | 0.605 |
t1/2 (h) | 61±31 | 83±16 | 0.298 |
tmax (h) | 4±4 | 12.±11 | 0.331 |
Vd (L/m2) | 3.7±1.2 | 3.3±1.1 | 0.684 |
aParameters of male vs female.